10th International Workshop on Molecular Targeted Therapy of Cancer (MTTC)

June 12-13, 2009, in Prague, Czech Republic

The 10th International Medical Education Workshop on Molecular Targeted Therapy of Cancer (MTTC), organized in partnership with the European Society for Medical Oncology (ESMO), the Central European Cooperative Oncology Group (CECOG) and the Biotherapy Development Association (BDA), was held June 12-13 in Prague. The workshop was chaired by Dr. Heinz Zwierzina from the Innsbruck Universitätsklinik in Austria and Dr. Yosef Yarden from the Weizmann Institute of Science in Israel.

A total of 93 oncologists attended the workshop. The scientific program was very well received by the participants, who also appreciated this forum for exchange of knowledge and experience between representatives of different expertise and
countries. According to the workshop evaluation, 100% of the participants felt that they increased their overall knowledge, 76% will consider using new drugs and 66% felt that they managed to establish valuable networking contacts. The overall
program was rated on a scale from 5 (strongly agree) to 1 (strongly disagree) with scores of 4.4 for “Quality of the education at this meeting was excellent”, 4.3 for “Product information was fair and balanced”, and 4.5 for “Management and organization of the meeting were excellent”.

On the occasion of the 10th International Medical Education Workshop on MTTC in Prague, the International Education Council on MTTC launched the Lifetime Achievement Award which honors recognized scientists, who have significantly contributed to the research and development of molecular targeted therapies of cancer. The renowned Dr. John Mendelsohn of MD Anderson Cancer Center, Texas, USA was elected as the first awardee.